{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T04:29:50Z","timestamp":1786768190982,"version":"build-2736575974"},"reference-count":52,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Background: Frontotemporal dementia (FTD) is a neurodegenerative disease that shares numerous clinical features with other forms of dementia. In this context, non-coding RNAs, specifically microRNAs (miRNAs), represent a promising tool for differential diagnosis. Since these miRNAs can be isolated from circulating extracellular vesicles (EVs) in peripheral blood, they provide a direct insight into FTD-specific molecular processes. Consequently, while EV-contained miRNAs hold potential as disease-specific biomarkers, investigating their relative target genes can help elucidate their precise functional roles. Aim: This work aimed to identify a specific miRNA signature to better characterize FTD pathology. Methods: Building on a previous Next-Generation Sequencing (NGS) analysis, three candidate miRNAs were selected for validation in both EVs and peripheral blood mononuclear cells (PBMCs) of FTD patients. Subsequently, the predicted target genes of two of these miRNAs were validated in PBMCs to assess their expression levels. Results: Our findings revealed that miR-365a-3p and miR-212 were significantly down-regulated in FTD. Conclusions: Together with their target genes, these miRNAs are involved in cell cycle and apoptotic pathways, suggesting a potential role in the pathological mechanisms of the disease.<\/jats:p>","DOI":"10.3390\/genes17080945","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T09:31:09Z","timestamp":1786613469000},"page":"945","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MicroRNA Signature in Plasma-Derived Extracellular Vesicles in Frontotemporal Dementia"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2689-1592","authenticated-orcid":false,"given":"Evelyne","family":"Minucchi","sequence":"first","affiliation":[{"name":"Department of Brain and Behavioral Sciences, University of Pavia, 27100 Pavia, Italy"},{"name":"Molecular Biology and Transcriptomics Unit, IRCCS Mondino Foundation, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7608-3306","authenticated-orcid":false,"given":"Francesca","family":"Dragoni","sequence":"additional","affiliation":[{"name":"Molecular Biology and Transcriptomics Unit, IRCCS Mondino Foundation, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7834-0342","authenticated-orcid":false,"given":"Rosalinda","family":"Di Gerlando","sequence":"additional","affiliation":[{"name":"Molecular Biology and Transcriptomics Unit, IRCCS Mondino Foundation, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Pavanello","sequence":"additional","affiliation":[{"name":"Department of Biology and Biotechnology \u201cLazzaro Spallanzani\u201d, University of Pavia, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Cotta Ramusino","sequence":"additional","affiliation":[{"name":"Unit of Behavioral Neurology and Dementia Research Center, IRCCS Mondino Foundation, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7312-8011","authenticated-orcid":false,"given":"Alfredo","family":"Costa","sequence":"additional","affiliation":[{"name":"Department of Brain and Behavioral Sciences, University of Pavia, 27100 Pavia, Italy"},{"name":"Unit of Behavioral Neurology and Dementia Research Center, IRCCS Mondino Foundation, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6589-6907","authenticated-orcid":false,"given":"Stella","family":"Gagliardi","sequence":"additional","affiliation":[{"name":"Molecular Biology and Transcriptomics Unit, IRCCS Mondino Foundation, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.12688\/f1000research.50786.1","article-title":"Epidemiology of Alzheimer\u2019s disease and other dementias: Rising global burden and forecasted trends","volume":"10","author":"Javaid","year":"2021","journal-title":"F1000Research"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.4103\/0028-3886.329593","article-title":"Frontotemporal Dementia\u2014Current Concepts","volume":"69","author":"Puppala","year":"2021","journal-title":"Neurol. India"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/bdi.12984","article-title":"Neuropsychiatric masquerades: Distinguishing neurodegenerative disease from bipolar disorder","volume":"22","author":"Ng","year":"2020","journal-title":"Bipolar Disord."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"544","DOI":"10.12968\/bjcn.2019.24.11.544","article-title":"Fronto-temporal dementia: A case study and strategies and support for caregivers","volume":"24","author":"Mulkey","year":"2019","journal-title":"Br. J. Community Nurs."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Antonioni, A., Raho, E.M., Lopriore, P., Pace, A.P., Latino, R.R., Assogna, M., Mancuso, M., Gragnaniello, D., Granieri, E., and Pugliatti, M. (2023). Frontotemporal Dementia, Where Do We Stand? A Narrative Review. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241411732"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41582-020-0330-x","article-title":"Development of disease-modifying drugs for frontotemporal dementia spectrum disorders","volume":"16","author":"Panza","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"ref_7","first-page":"1642","article-title":"Frontotemporal Dementia","volume":"30","author":"Clark","year":"2024","journal-title":"Continuum (Minneap. Minn.)"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.1002\/alz.13363","article-title":"Frontotemporal dementia: Past, present, and future","volume":"19","author":"Ulugut","year":"2023","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1017\/cjn.2022.69","article-title":"Recent Advances in Frontotemporal Dementia","volume":"50","author":"Tartaglia","year":"2023","journal-title":"Can. J. Neurol. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41573-022-00410-w","article-title":"Therapeutically harnessing extracellular vesicles","volume":"21","author":"Cheng","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Witwer","year":"2018","journal-title":"J. Extracell. Vesicles"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.mam.2017.11.006","article-title":"Extracellular vesicles in neurodegenerative diseases","volume":"60","author":"Croese","year":"2018","journal-title":"Mol. Asp. Med."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Xu, D., Di, K., Fan, B., Wu, J., Gu, X., Sun, Y., Khan, A., Li, P., and Li, Z. (2022). MicroRNAs in extracellular vesicles: Sorting mechanisms, diagnostic value, isolation, and detection technology. Front. Bioeng. Biotechnol., 10.","DOI":"10.3389\/fbioe.2022.948959"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1111\/febs.16422","article-title":"The intricate balance between microRNA-induced mRNA decay and translational repression","volume":"290","author":"Naeli","year":"2023","journal-title":"FEBS J."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Nardozi, D., Lucarini, V., Angiolini, V., Feverati, N., Benvenuto, M., Focaccetti, C., Del Conte, L., Buccitti, O., Palumbo, C., and Cifaldi, L. (2025). Extracellular Vesicle-Derived microRNAs: Novel Non-Invasive Biomarkers for Gastrointestinal Malignancies. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27010010"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40035-016-0053-5","article-title":"MiRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer\u2019s disease and other types of dementia\u2014an exploratory study","volume":"5","author":"Nygaard","year":"2016","journal-title":"Transl. Neurodegener."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40035-022-00296-z","article-title":"Advances in the development of new biomarkers for Alzheimer\u2019s disease","volume":"11","author":"Klyucherev","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Di Gerlando, R., Dragoni, F., Minucchi, E., Garofalo, M., Perini, G., Costa, A., Pisani, A., Morasso, C., Cotta Ramusino, M., and Gagliardi, S. (2026). Plasma-Derived miRNAs as Fluid Biomarkers to Differentiate Alzheimer\u2019s and Frontotemporal Dementia. Curr. Issues Mol. Biol., 48.","DOI":"10.3390\/cimb48060633"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/brain\/awr179","article-title":"Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia","volume":"134","author":"Rascovsky","year":"2011","journal-title":"Brain"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/21678421.2016.1267768","article-title":"Amyotrophic lateral sclerosis\u2014Frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria","volume":"18","author":"Strong","year":"2017","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","article-title":"Classification of primary progressive aphasia and its variants","volume":"76","author":"Hillis","year":"2011","journal-title":"Neurology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"D147","DOI":"10.1093\/nar\/gkae1072","article-title":"MiRTarBase 2025: Updates to the collection of experimentally validated microRNA-target interactions","volume":"53","author":"Cui","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: Protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Licursi, V., Conte, F., Fiscon, G., and Paci, P. (2019). MIENTURNET: An interactive web tool for microRNA-target enrichment and network-based analysis. BMC Bioinform., 20.","DOI":"10.1186\/s12859-019-3105-x"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-1-0716-2815-7_14","article-title":"MicroRNA Regulatory Network Analysis Using miRNet 2.0","volume":"2594","author":"Chang","year":"2023","journal-title":"Methods Mol. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"104734","DOI":"10.1016\/j.neuint.2020.104734","article-title":"MicroRNA-212-3p regulates early neurogenesis through the AKT\/mTOR pathway by targeting MeCP2","volume":"137","author":"Zhai","year":"2020","journal-title":"Neurochem. Int."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s10529-020-02915-z","article-title":"MicroRNA miR-212 regulates PDCD4 to attenuate A\u03b225-35-induced neurotoxicity via PI3K\/AKT signaling pathway in Alzheimer\u2019s disease","volume":"42","author":"Wang","year":"2020","journal-title":"Biotechnol. Lett."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1093\/hmg\/ddt164","article-title":"De-repression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer\u2019s disease","volume":"22","author":"Wong","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3233\/JAD-122350","article-title":"A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer\u2019s disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls","volume":"35","author":"Wang","year":"2013","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Wang, Z. (2021). Regulation of Cell Cycle Progression by Growth Factor-Induced Cell Signaling. Cells, 10.","DOI":"10.3390\/cells10123327"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"815","DOI":"10.7150\/ijbs.20052","article-title":"FOXO Signaling Pathways as Therapeutic Targets in Cancer","volume":"13","author":"Farhan","year":"2017","journal-title":"Int. J. Biol. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/978-1-4419-1599-3_11","article-title":"New insights for FOXO and cell-fate decision in HIV infection and HIV associated neurocognitive disorder","volume":"665","author":"Cui","year":"2009","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"167.e1","DOI":"10.1016\/j.neurobiolaging.2016.09.019","article-title":"The miRNome of Alzheimer\u2019s disease: Consistent downregulation of the miR-132\/212 cluster","volume":"50","author":"Pichler","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/emmm.201201974","article-title":"Alteration of the microRNA network during the progression of Alzheimer\u2019s disease","volume":"5","author":"Lau","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"946","DOI":"10.14336\/AD.2019.0923","article-title":"Cell Cycle Deficits in Neurodegenerative Disorders: Uncovering Molecular Mechanisms to Drive Innovative Therapeutic Development","volume":"11","author":"Joseph","year":"2020","journal-title":"Aging Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3727\/096368916X694184","article-title":"Regulator of Cell Cycle (RGCC) Expression during the Progression of Alzheimer\u2019s Disease","volume":"26","author":"Counts","year":"2017","journal-title":"Cell Transplant."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Maximino, J.R., de Oliveira, G.P., Alves, C.J., and Chadi, G. (2014). Deregulated expression of cytoskeleton related genes in the spinal cord and sciatic nerve of presymptomatic SOD1(G93A) Amyotrophic Lateral Sclerosis mouse model. Front. Cell Neurosci., 8.","DOI":"10.3389\/fncel.2014.00148"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/jcp.26816","article-title":"Effect of CCNB1 silencing on cell cycle, senescence, and apoptosis through the p53 signaling pathway in pancreatic cancer","volume":"234","author":"Zhang","year":"2018","journal-title":"J. Cell Physiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41419-020-2647-1","article-title":"Aberrant activation of neuronal cell cycle caused by dysregulation of ubiquitin ligase Itch results in neurodegeneration","volume":"11","author":"Chauhan","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"111290","DOI":"10.1016\/j.mad.2020.111290","article-title":"Serum FOXO3A: A ray of hope for early diagnosis of Alzheimer\u2019s disease","volume":"190","author":"Pradhan","year":"2020","journal-title":"Mech. Ageing Dev."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1242\/jcs.185009","article-title":"Cdk5-Foxo3 axis: Initially neuroprotective, eventually neurodegenerative in Alzheimer\u2019s disease models","volume":"129","author":"Shi","year":"2016","journal-title":"J. Cell Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3892\/or.2016.4617","article-title":"MicroRNA-365a-3p promotes tumor growth and metastasis in laryngeal squamous cell carcinoma","volume":"35","author":"Geng","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_43","first-page":"206","article-title":"The role of the microRNA regulatory network in Alzheimer\u2019s disease: A bioinformatics analysis","volume":"18","author":"Sun","year":"2022","journal-title":"Arch. Med. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3233\/JAD-180539","article-title":"Validation of MicroRNA Biomarkers for Alzheimer\u2019s Disease in Human Cerebrospinal Fluid","volume":"67","author":"Wiedrick","year":"2019","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3233\/JAD-200396","article-title":"Performance of Validated MicroRNA Biomarkers for Alzheimer\u2019s Disease in Mild Cognitive Impairment","volume":"78","author":"Sandau","year":"2020","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1747-1028-1-32","article-title":"Variations in cyclin D1 levels through the cell cycle determine the proliferative fate of a cell","volume":"1","author":"Yang","year":"2006","journal-title":"Cell Div."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1038\/s41388-021-01881-8","article-title":"PARP14 regulates cyclin D1 expression to promote cell-cycle progression","volume":"40","author":"Thakar","year":"2021","journal-title":"Oncogene"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1007\/s00018-019-03428-3","article-title":"Molecular crosstalk between cancer and neurodegenerative diseases","volume":"77","author":"Seo","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Santos-Lobato, B.L., Vidal, A.F., and Ribeiro-Dos-Santos, \u00c2. (2021). Regulatory miRNA\u2013mRNA Networks in Parkinson\u2019s Disease. Cells, 10.","DOI":"10.3390\/cells10061410"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2990.2010.01064.x","article-title":"Review: Cell cycle aberrations and neurodegeneration","volume":"36","author":"Bonda","year":"2010","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"119302","DOI":"10.1016\/j.lfs.2021.119302","article-title":"Src homolog and collagen homolog1 isoforms in acute and chronic liver injuries","volume":"273","author":"Ma","year":"2021","journal-title":"Life Sci."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Fischer, S., and Deindl, E. (2021). Characterization of RNA in Extracellular Vesicles. Appl. Sci., 11.","DOI":"10.3390\/app11167520"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/17\/8\/945\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T04:24:41Z","timestamp":1786767881000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/17\/8\/945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":52,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["genes17080945"],"URL":"https:\/\/doi.org\/10.3390\/genes17080945","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]}}}